404
+1-313-307-4176
Viral Clearance Market Report
The Market is Segmented by Application Type (Recombinant Proteins, Blood & Blood Products, Vaccines, and Others), by End-User Type (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Others), by Method Type ...
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
Viral clearance market is likely to witness an impressive CAGR of 22.3% during the forecast period. Growth in the pharmaceutical and biotechnology industries, R&D investment in life science, surge in number of drug launches, developments in nanofiltration technology, and increasing burden of chronic diseases are the major factors that are contributing towards the growth of the viral clearance market.
|
Viral Clearance Market - Snapshot |
|
|
Growth |
22.3% for the next five years |
|
Major End-User Type |
Contract research organization |
|
Dominant Method Type |
Viral removal |
|
Region with the highest demand |
North America |
|
Key Players |
Merck Group, Charles River Laboratories Inc., Kedrion S.p.A., Vironova AB, Texcell, Clean Cells, BSL BIOSERVICE Scientific Laboratories Munich GmbH, and ViruSure GmbH. |
Wish to Get a Free Sample? Click here.
Based on the end-user type, the market is segmented as pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and others. The contract research organizations’ segment is expected to portray the highest growth during the forecast period. Ability of contract research organizations to invest extensively in drug discovery infrastructure and increased outsourcing of drug discovery services to CROs by institutions, such as start-ups, academic institutes, pharmaceutical companies, and small biotechnology companies are the major factors behind their extraordinary growth in the global viral clearance market.
Based on the method type, the viral clearance market is segmented as viral removal and viral inactivation. The viral removal segment is expected to lead the market during the forecast period owing to growth in R&D activities by biopharmaceutical companies; high accuracy, speed, and flexibility provided by the method in life sciences research, and increasing acceptance of the method in the industry.
In terms of regions, North America dominated the viral clearance market and is expected to witness substantial growth during the forecast period. Presence of national institutes supporting life science and biotechnology research, significant growth in the pharmaceutical industry, and continuous increase in drug approvals are the major factors driving the viral clearance market in the region. Asia-Pacific is expected to witness the highest growth during the forecast period, owing to government support in countries, such as China, Japan, and India; rise in pharmaceutical R&D expenditures, government support and rising awareness towards generic drugs, along with the increasing number of CROs to provide preclinical and clinical research services.
Some of the major players in the viral clearance market are Merck Group, Charles River Laboratories, Inc., Kedrion S.p.A., Vironova AB, Texcell, Clean Cells, BSL BIOSERVICE Scientific Laboratories Munich GmbH, and ViruSure GmbH.
Viral Clearance is removing of viral contamination through chromatography or by making use of some specialized membranes. The process of viral clearance is done in order to make sure that drugs from different sources are free from any kind of viral contamination.
Viral Clearance can take through the method of viral removal and viral inactivation. The process is used for different options such as blood or blood products, recombinant proteins, vaccines, and others. Biotechnology and pharmaceutical companies, academic research institutes, and contract research organizations are some of the places where the process is highly needed.
This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
|
Viral Clearance Market Research Report - Features |
|
|
Market Segmentation |
4 ways |
|
Regions Covered |
4 |
|
Countries/Sub-Regions Covered |
15 |
|
No. of Figures & Tables |
>150 |
|
Company Profiles |
8 |
The viral clearance market is segmented into the following categories.
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Market Segmentation
Competitive Benchmarking
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
WE ACCEPT
